Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (331-340 of 759) with videos related to

Pageof 76
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2017
Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk CytogeneticsRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
Haematologica|May 6, 2017
Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantationRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
British Journal of Haematology|August 13, 2014
Quantification of clonal circulating plasma cells in relapsed multiple myelomaWilson I Gonsalves, William G Morice, Vincent Rajkumar, et al.
Leukemia & Lymphoma|October 29, 2020
Retroperitoneal involvement with light chain amyloidosis- case series and literature reviewIuliana Vaxman, Alissa Visram, Oren Pasvolsky, et al.
American Journal of Hematology|February 18, 2011
Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosisShaji K Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
Transplantation and Cellular Therapy|April 10, 2021
Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple MyelomaHarsh Parmar, Abdullah S Al Saleh, Alissa Visram, et al.
British Journal of Haematology|November 29, 2024
Autologous stem cell transplantation for multiple myeloma patients whose myeloma-defining event was SLiMIuliana Vaxman, Shaji Kumar, Inbar Cohen, et al.
Blood|June 16, 2011
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myelomaSumit Madan, Martha Q Lacy, Angela Dispenzieri, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 15, 2011
Utility of Doppler myocardial imaging, cardiac biomarkers, and clonal immunoglobulin genes to assess left ventricular performance and stratify risk following peripheral blood stem cell transplantation in patients with systemic light chain amyloidosis (Al)Diego Bellavia, Roshini S Abraham, Patricia A Pellikka, et al.
Blood|October 24, 2002
Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosisAnimesh Pardanani, Thomas E Witzig, Georgene Schroeder, et al.
Pageof 76

Showing results (331-340 of 759) with videos related to

Sort By:
Pageof 76
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2017
Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk CytogeneticsRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
Haematologica|May 6, 2017
Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantationRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
British Journal of Haematology|August 13, 2014
Quantification of clonal circulating plasma cells in relapsed multiple myelomaWilson I Gonsalves, William G Morice, Vincent Rajkumar, et al.
Leukemia & Lymphoma|October 29, 2020
Retroperitoneal involvement with light chain amyloidosis- case series and literature reviewIuliana Vaxman, Alissa Visram, Oren Pasvolsky, et al.
American Journal of Hematology|February 18, 2011
Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosisShaji K Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
Transplantation and Cellular Therapy|April 10, 2021
Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple MyelomaHarsh Parmar, Abdullah S Al Saleh, Alissa Visram, et al.
British Journal of Haematology|November 29, 2024
Autologous stem cell transplantation for multiple myeloma patients whose myeloma-defining event was SLiMIuliana Vaxman, Shaji Kumar, Inbar Cohen, et al.
Blood|June 16, 2011
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myelomaSumit Madan, Martha Q Lacy, Angela Dispenzieri, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 15, 2011
Utility of Doppler myocardial imaging, cardiac biomarkers, and clonal immunoglobulin genes to assess left ventricular performance and stratify risk following peripheral blood stem cell transplantation in patients with systemic light chain amyloidosis (Al)Diego Bellavia, Roshini S Abraham, Patricia A Pellikka, et al.
Blood|October 24, 2002
Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosisAnimesh Pardanani, Thomas E Witzig, Georgene Schroeder, et al.
Pageof 76